Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Comparative efficacy of glucocorticoid receptor agonists on Th2 cell function and attenuation by progesterone

Fig. 2

A comparison of prednisolone- and dexamethasone-induced apoptosis in a Th2 cell line (CCRF-CEM). Data are expressed as percentage of 7AAD+ cells (a) identifying dead cells. The half maximal dose (EC50) for prednisolone and dexamethasone required to induce necrosis of cells (b). Percentage of Annexin V+ 7AAD− cells, identifying apoptotic cells (c). A comparison of the EC50 values for prednisolone and dexamethasone required to reach 50% maximal induction of apoptosis in cells (d; n = 11). Percentage of Annexin V+ 7AAD− primary Th2 cells following treatment with dexamethasone, exhibiting a similar plateau effect as CCRF-CEM at 0.5 μM dexamethasone (e; n = 3). Comparison of CS-induced apoptosis in CCRF-CEM as fold-difference over vehicle (f). Data represent mean and standard error. Pred, prednisolone; Dex, dexamethasone. *p < 0.05 determined by two-way (a & c), t-test (b & e) or one-way RM ANOVA (g)

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us